Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond
- PMID: 25870795
- PMCID: PMC4384221
- DOI: 10.3978/j.issn.2218-6751.2015.01.10
Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond
Abstract
Somatic mutational profiling in cancer has revolutionized the practice of clinical oncology. The discovery of driver mutations in non-small cell lung cancer (NSCLC) is an example of this. Molecular testing of lung adenocarcinoma is now considered standard of care and part of the diagnostic algorithm. This article provides an overview of the workflow of molecular testing in a clinical diagnostic laboratory discussing in particular novel assays that are currently in use for somatic mutation detection in NSCLC focussing on epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK), ROS1 and RET rearrangements.
Keywords: Epidermal growth factor receptor (EGFR); RET; ROS1; anaplastic lymphoma kinase (ALK).
References
-
- Pao W, Hutchinson KE. Chipping away at the lung cancer genome. Nat Med 2012;18:349-51. - PubMed
-
- Midthun DE. Available online: http://www.uptodate.com/contents/overview-of-the-risk-factors-pathology-.... [Accessed on Jan 13, 2014].
-
- Vnencak-Jones CL, Berger MF, Pao W. Types of Molecular Tumor Testing. My Cancer Genome 2014. Available online: http://www.mycancergenome.org/content/molecular-medicine/types-of-molecu.... [Accessed on Aug 8, 2014].
-
- Cagle PT, Sholl LM, Lindeman NI, et al. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Non-Small Cell Carcinoma of the Lung. Available online: http://www.cap.org/ShowProperty?nodePath=/UCMCon/Contribution Folders/We... - PubMed
-
- Cancer Protocols. Available online: http://www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology...
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous